Anebulo Pharmaceuticals, Inc. ANEB

Set alert

Price alert · ANEB

All alert types
0.24 USD -0.02 -6.92%

At close · Oct 30

0.38 +0.14 +57.81%

After hours · Oct 30, 4:00 PM ET

Bid
0.36 × 2,500
Ask
0.37 × 2,500
0.8699 Day range 0.8699
0.001 52-week range 2.56
YTD
-76.04%
1 year
-90.83%
Open
0.8699
Prev close
0.26
Mkt cap
9.87M
Vol
100
Avg vol
184
EPS
-0.19
P/E
0.00
Div yield
0.00%
More statistics
Low
0.8699
High
0.8699
Forward P/E
-2.49
Beta
-1.01
Short ratio
1.94
Inst. own
28.32%
Dividend
0.00
Ex-div date
Earnings
Feb 11, 2025
50-d avg
1.60
200-d avg
2.14
1y target
8.00

1D chart

Chart tools
Interval

Analyst view

Consensus: none

Price target (mean) 8.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1
  • 1 month ago 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ANEB analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.08-0.08 – -0.08-0.11+27.3%00.0%1
Next quarter-0.08-0.08 – -0.08-0.06-33.3%00.0%1
Current year-0.33-0.33 – -0.330.000.0%00.0%1
Next year0.000.00 – 0.00-0.330.0%00.0%0

Upgrades and downgrades

The latest rating changes

ANEB analyst upgrades and downgrades
DateFirmActionFromTo
Nov 19, 2024BenchmarkReiteratedSpeculative BuySpeculative Buy
Oct 1, 2024BenchmarkReiteratedSpeculative BuySpeculative Buy
Oct 3, 2023BenchmarkReiteratedSpeculative BuySpeculative Buy
Sep 25, 2023HC Wainwright & Co.ReiteratedBuyBuy
Sep 21, 2023Maxim GroupInitiated—Buy
Sep 18, 2023HC Wainwright & Co.Initiated—Buy
May 18, 2023BenchmarkReiteratedSpeculative BuySpeculative Buy
Feb 14, 2023BenchmarkMaintained—Speculative Buy
Jul 27, 2022Ladenburg ThalmannInitiated—Buy
May 25, 2021BenchmarkInitiated—Buy